The global flu shots market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is likely to fuel the growth of the market includes an increase in the prevalence of flu epidemics and seasonal outbreaks. The viral infection which occurs due to flu in the respiratory system is referred to as influenza. The influenza virus travels through respiratory droplets and is contagious. It can also spread from one person to another while talking or due to physical contact. The changing character of the flu virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations globally such as the Centers for Disease Control and Prevention (CDC) have suggested vaccines such as baloxavir marboxil (Xofluza) for the treatment of influenza, and have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/flu-shots-market
The vaccines used for influenza are made up of three different influenza viruses such as influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Moreover, an increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the major factors driving the market growth. In addition, an increase in investment by leading market players across the globe and a rise in government funding has facilitated the launch of therapeutically effective vaccines, which is another factor that is expected to augment the growth of the market during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Application
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape: GlaxoSmithKline plc, Sanofi S.A., and Sinovac Biotech Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Flu Shots Market Report by Segment
By Type
- Influenza Virus Split Vaccines
- Influenza Virus Subunit Vaccines
- Influenza Whole Virus Vaccines
By Application
- Aviation Influenza Virus A
- Aviation Influenza Virus B
A full report of Flu Shots Market is available at: https://www.omrglobal.com/industry-reports/flu-shots-market
Flu Shots Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- GlaxoSmithKline plc
- Sanofi S.A.
- Sinovac Biotech Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
